Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Stock-Based Compensation (Details 2)

v3.20.1
Stockholders' Equity and Stock-Based Compensation (Details 2)
 3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Stockholders' Equity and Stock-Based Compensation (Details 2)  
Options outstanding, Beginning of the period | $ $ 518,551
Options outstanding, Granted | shares
Options outstanding, Exercised | shares
Options outstanding, Forfeited | shares
Options outstanding, Expired | shares (1,397)
Options outstanding, End of the period | shares 517,154
Options outstanding, options exercisable | shares 432,281
Weighted Average Exercise Price Beginning of the period $ 21.99
Weighted Average Exercise Price Stock Options Granted
Weighted Average Exercise Price Stock Options Exercised
Weighted Average Exercise Price Stock Options Forfeited
Weighted Average Exercise Price Stock Options Expired 519.00
Weighted Average Exercise Price End of the year 20.64
Weighted Average Exercise Price Options exercisable 22.59
Weighted Average Fair Value Stock Options Beginning of the period 15.89
Weighted Average Fair Value Stock Options Granted
Weighted Average Fair Value Stock Options Exercised
Weighted Average Fair Value Stock Options Forfeited
Weighted Average Fair Value Stock Options Expired 467.31
Weighted Average Fair Value Stock Options End of the year 14.67
Weighted Average Fair Value Options exercisable $ 15.93